Clinical Trial Update: A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating the effect of Triferic plus heparin infusion versus heparin alone on coagulation parameters in patients with end-stage renal diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Heparin (unfractionated heparin)
• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-12